Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Innoviva Inc (NASDAQ:INVA)

11.53
Delayed Data
As of 4:00pm ET
 -0.08 / -0.69%
Today’s Change
6.36
Today|||52-Week Range
19.96
+9.39%
Year-to-Date

Today’s Trading

Previous close11.61
Today’s open11.59
Day’s range11.39 - 11.72
Volume276,644
Average volume (3 months)720,266
Market cap$1.4B
Dividend yield8.68%
Data as of 4:00pm ET, 05/05/2016

Growth & Valuation

Earnings growth (last year)+89.33%
Earnings growth (this year)+481.25%
Earnings growth (next 5 years)+3.00%
Revenue growth (last year)+247.57%
P/E ratioNM
Price/Sales17.94
Price/Book--

Competitors

 Today’s
change
Today’s
% change
ALDRAlder Biopharmaceuti...-0.63-2.44%
CXRXConcordia Healthcare...-0.51-1.87%
ACORAcorda Therapeutics ...+0.18+0.71%
PRTAProthena Corporation...+0.17+0.44%
Data as of 4:00pm ET, 05/05/2016

Financials

Next reporting dateJuly 27, 2016
EPS forecast (this quarter)$0.12
Annual revenue (last year)$67.8M
Annual profit (last year)-$18.8M
Net profit margin-27.68%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Michael W. Aguiar
Chief Financial Officer &
Senior Vice President
Eric d'Esparbes
Corporate headquarters
South San Francisco, California

Forecasts

Partner Offers

Search for Jobs